Screener
Jazz Pharmaceuticals JAZZ Deferred Income Tax Expense (Benefit), Increase (Decrease) In Tax Rate
Deferred Income Tax Expense (Benefit), Increase (Decrease) In Tax Rate at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept jazz:DeferredIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate.
The source filing: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026.
- Filed
- Feb 24, 2026, 4:10 PM EST
- Fiscal year
- FY2028
- Accession
- 0001232524-26-000013
| Line item | Year Ended December 31, 2025 | Year Ended December 31, 2024 | Year Ended December 31, 2023 |
|---|---|---|---|
| United States | (2,075) | 955 | (824) |
| United Kingdom | — | — | 268 |
| Other | — | (17) | — |
| Total deferred, change in tax rates | (2,075) | 938 | (556) |
| Total deferred tax benefit | (444,971) | (208,327) | (260,217) |
| Total income tax expense (benefit) | |||
| Ireland | 61,807 | 77,658 | 66,424 |
| United States | (254,537) | (40,142) | (69,267) |
Item 16. Form 10-K Summary
FAQ
- What is Jazz Pharmaceuticals's deferred income tax expense (benefit), increase (decrease) in tax rate?
- Jazz Pharmaceuticals (JAZZ) reported deferred income tax expense (benefit), increase (decrease) in tax rate of -$518.75K in Q4 2025.
- How has Jazz Pharmaceuticals's deferred income tax expense (benefit), increase (decrease) in tax rate changed year-over-year?
- Jazz Pharmaceuticals's deferred income tax expense (benefit), increase (decrease) in tax rate decreased by 321.2% year-over-year, from $234.5K to -$518.75K.
- What is the long-term trend for Jazz Pharmaceuticals's deferred income tax expense (benefit), increase (decrease) in tax rate?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's deferred income tax expense (benefit), increase (decrease) in tax rate has grown at a -70.1% compound annual growth rate (CAGR), from $261.26M to -$2.08M.
- What does deferred income tax expense (benefit), increase (decrease) in tax rate mean?
- Reflects the impact on deferred tax assets and liabilities resulting from changes in enacted tax laws or statutory tax rates. This captures the revaluation of existing deferred tax balances due to legislative shifts.
Ask your AI about Jazz Pharmaceuticals's deferred income tax expense (benefit), increase (decrease) in tax rate.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude